Neuroaliados Medicina Especializada S.A.S. (Colombia)

Main Activities: Ambulatory Health Care Services

Secondary Activities: Machinery, Equipment, and Supplies Merchant Wholesalers | Drugs and Druggists' Sundries Merchant Wholesalers | Offices of Real Estate Agents and Brokers

Full name: Neuroaliados Medicina Especializada S.A.S.

Profile Updated: October 02, 2025

Neuroaliados Medicina Especializada S.A.S. is based in Colombia. The head office is in Cucuta. The company operates in the Ambulatory Health Care Services industry. The company was established on October 20, 2011. 11 (2018) employees currently work for Neuroaliados Medicina Especializada S.A.S.. The company’s latest financial report indicates a net sales revenue increase of 18.33% in 2024. During that time, Neuroaliados Medicina Especializada S.A.S.’s total assets grew by 0.44%. The net profit margin of Neuroaliados Medicina Especializada S.A.S. decreased by 16.17% in 2024.

Headquarters
Cll14A Nro 2E - 85 Pi 6
Cucuta; Norte de Santander;

Contact Details: Purchase the Neuroaliados Medicina Especializada S.A.S. report to view the information.

Basic Information

Total Employees:

Purchase the Neuroaliados Medicina Especializada S.A.S. report to view the information.

Registered Capital:

Purchase the Neuroaliados Medicina Especializada S.A.S. report to view the information.

Financial Auditors:

Purchase the Neuroaliados Medicina Especializada S.A.S. report to view the information.

Incorporation Date:

October 20, 2011

Key Executives

Purchase this report to view the information.

Legal Representative

Company Performance

Financial values in the chart are available after Neuroaliados Medicina Especializada S.A.S. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.

Net sales revenue

18.33%▲

Total operating revenue

18.33%▲

Operating profit (EBIT)

-42.7%▼

EBITDA

-31.77%▼

Net Profit (Loss) for the Period

-37.37%▼

Total Assets

0.44%▲

Total Equity

-2.34%▼

Operating Profit Margin (ROS)

-22.42%▼

Net Profit Margin

-16.17%▼

Return on Equity (ROE)

-13.75%▼

Debt/Equity

-0.02%▼

Quick Ratio

-0.12%▼

Cash Ratio

0.06%▲

Similar companies

Related EMIS Industry Reports